Lin; Biaoyang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lin; Biaoyang.The latest application filed is for "diagnosis, prognosis and treatment of glioblastoma multiforme".

Company Profile

0.15.17

Lin; Biaoyang - Hangzhou N/A CN
LIN; Biaoyang - Bothell WA
Lin; Biaoyang - London GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sample hepatocarcinoma classification with YKL-40 to MASP2 concentration ratio Grant 11,193,934 - Lin December 7, 2	2021-12-07
Diagnosis, Prognosis And Treatment Of Glioblastoma Multiforme App 20160222468 - LIN; Biaoyang ; et al.	2016-08-04
Methods for identifying and using organ-specific proteins in blood Grant 9,234,895 - Hood , et al. January 12, 2	2016-01-12
Methods for identifying and using organ-specific proteins in blood Grant 9,002,652 - Hood , et al. April 7, 2	2015-04-07
Methods for Identifying and Monitoring Drug Side Effects App 20140228229 - Hood; Leroy ; et al.	2014-08-14
Methods for identifying and monitoring drug side effects Grant 8,603,752 - Hood , et al. December 10, 2	2013-12-10
Methods For Identifying And Using Organ-specific Proteins In Blood App 20130045873 - HOOD; Leroy ; et al.	2013-02-21
Prostate-specific polypeptide PAMP and encoding nucleic acid molecules Grant 8,143,010 - Lin March 27, 2	2012-03-27
Diagnosis, Prognosis And Treatment Of Glioblastoma Multiforme App 20110301221 - Lin; Biaoyang ; et al.	2011-12-08
Methods For Identifying And Monitoring Drug Side Effects App 20110136690 - HOOD; LEROY ; et al.	2011-06-09
Method and a Reagent kit to Improve the Accuracy of Sample Classification App 20110065120 - Lin; Biaoyang	2011-03-17
Methods And Reagent Kits For Improving Accuracy Of Sample Classification App 20110065098 - Lin; Biaoyang	2011-03-17
Methods for identifying and monitoring drug side effects Grant 7,883,858 - Hood , et al. February 8, 2	2011-02-08
Androgen regulated prostate specific nucleic acids Grant 7,807,785 - Lin October 5, 2	2010-10-05
Methods For Identifying And Monitoring Drug Side Effects App 20100075866 - Hood; Leroy ; et al.	2010-03-25
Androgen regulated nucleic acid molecules and encoded proteins App 20090075255 - Lin; Biaoyang	2009-03-19
Androgen regulated prostate specific nucleic acids App 20090069539 - Lin; Biaoyang	2009-03-12
Prostate-specific Polypeptide Pamp And Encoding Nucleic Acid Molecules App 20090042202 - Lin; Biaoyang	2009-02-12
Prostate-specific polypeptide pamp and encoding nucleic acid molecules Grant 7,393,921 - Lin July 1, 2	2008-07-01
Androgen regulated prostate specific nucleic acids Grant 7,071,303 - Lin July 4, 2	2006-07-04
Androgen regulated prostate specific polypeptide-5 (ARP-5) App 20040253622 - Lin, Biaoyang	2004-12-16
Androgen regulated nucleic acid molecules and encoded proteins App 20040137440 - Lin, Biaoyang	2004-07-15
Androgen regulated prostate specific nucleic acids App 20030166520 - Lin, Biaoyang	2003-09-04
Androgen regulated nucleic acid molecules and encoded proteins App 20030144188 - Lin, Biaoyang	2003-07-31
Prostate-specific polypeptide pamp and encoding nucleic acid molecules App 20020150893 - Lin, Biaoyang	2002-10-17
Mouse model for Huntington's Disease and related DNA sequences Grant 5,849,995 - Hayden , et al. December 15, 1	1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.